//
Koji Kawaguchi
Kohei Yokoi
Hiroshi Niwa
Yasuhisa Ohde
Shoichi Mori
Sakae Okumura
Satoshi Shiono
Hiroyuki Ito
Motoki Yano
Kikuo Shigemitsu
Yoshinori Hiramatsu
Jiro Okami
Hideo Saka
Department of Thoracic Surgery, Nagoya University, Nagoya, Japan
Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, Hamamatsu, Japan
Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan
Department of Thoracic Surgery, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Japan
Department of Thoracic Surgical Oncology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan
Division of Thoracic Surgery, Thoracic Oncology, and Pathology, Kanagawa Cancer Center, Yokohama, Japan
Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Department of Thoracic Surgery, Ogaki Municipal Hospital, Ogaki, Japan
Department of Thoracic Surgery, Toyota Kosei Hospital, Toyota, Japan
Department of General Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
Nagoya Medical Center, Nagoya, Japan
Japan
N/A
Oncology (ONC)
Non Small Cell Lung cancer
N/A
Vinorelbine
Cisplatin
N/A
Multicenteric
Prospective
II
UMIN000001810
N/A
Final